High Prevalence of EGFR Mutations in Lung Adenocarcinomas From Brazilian Patients Harboring the TP53 p.R337H Variant

Clin Lung Cancer. 2020 Mar;21(2):e37-e44. doi: 10.1016/j.cllc.2019.11.012. Epub 2019 Nov 28.

¹ Medical Oncology Department, A. C. Camargo Cancer Center, São Paulo, Brazil.
² Medical Oncology Department, A. C. Camargo Cancer Center, São Paulo, Brazil; Translational Immuno-oncology Laboratory, International Research Center, A. C. Camargo Cancer Center, São Paulo, Brazil. Electronic address: vladmir.lima@accamargo.org.br.
³ Genomics and Molecular Biology Laboratory, CIPE, A. C. Camargo Cancer Center, São Paulo, Brazil.
⁴ Genomics and Molecular Biology Laboratory, CIPE, A. C. Camargo Cancer Center, São Paulo, Brazil; National Institute of Science and Technology in Oncogenomics (INCITO), São Paulo, Brazil.
⁵ Genomics and Molecular Biology Laboratory, CIPE, A. C. Camargo Cancer Center, São Paulo, Brazil; National Institute of Science and Technology in Oncogenomics (INCITO), São Paulo, Brazil. Electronic address: dirce.carraro@accamargo.org.br.

No abstract available

Keywords: EGFR mutation; Hereditary cancer; Li-Fraumeni syndrome; Lung adenocarcinoma; p.R337H mutation.

Publication types